FDA allows more e-cigarettes and nicotine pouches to market without full vetting
The FDA posted guidelines allowing companies to launch certain nicotine-based products before full regulatory review, departing from longstanding policy requiring scientific verification. Senior FDA tobacco officials were not consulted and learned of the decision the night before publication. The memo appeared days before FDA Commissioner Marty Makary resigned, prompting internal confusion about authorization and implementation.
2
Divergence score
4 outlets covered it, splitting into 3 framing camps across 2 bias groups.
3 camps
2 bias groups
The spectrum · how 4 outlets placed this story
LeftCenterRight
PBS NewsHour
CNN
AP News
Reuters
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
The split, in one line
Coverage splits between internal FDA dissent (AP) and industry victory (Reuters), with both reporting the same policy shift but diverging on whether to emphasize bureaucratic surprise or regulatory rollback consequences.
How each outlet covered it
Only the left is covering this
One side of the spectrum has stayed silent. That absence is itself a signal.
THE LEFT
“FDA staff blindsided by move allowing more e-cigarettes and nicotine pouches onto US market”CNN CNN LEFT
0RIGHT OUTLETS
0
RIGHT OUTLETS
0 of 4 outlets covering this story sit on that side of the spectrum.
DOWN THE MIDDLE
“Big Tobacco comes out on top after US FDA shake-up” · PBS NewsHour, AP News, Reuters
+Hide the full sourcingSee how all 4 outlets put it
Tracked claims from across the political spectrum
Fact ledger
Corroborated
Disputed